Getting the Symplicity Renal Denervation System

This minimally invasive endovascular procedure, using the Symplicity renal denervation system disrupts the renal nerves via the renal arteries using radio frequency (RF) energy. The device and procedure produce precise, complete and replicable renal denervation (RDN) without the risks of invasive surgery or requiring a permanent implant.

What to expect

The endovascular operation is performed by interventionalists, a group of physicians who are technically adept at catheter procedures, within the infrastructure of a standard catheterization lab. The operator introduces a guiding catheter through the femoral artery and threads it up to the target renal artery. The Symplicity catheter is then inserted into the renal artery through the guide catheter and, using radio frequency energy, ablates the nerves from the inside of the artery, without damaging the renal artery. After ablation, the device is withdrawn and the arterial access site may be closed as with standard interventional techniques.

  1. Symplicity is a trademark of Medtronic, Inc. and is registered in one or more countries of the world.

Information on this site should not be used as a substitute for talking with your doctor. Always talk with your doctor about diagnosis and treatment information.

Last updated: 3 Apr 2012

Section Navigation

Additional information

Take Charge

    • Medtronic RDN Screenshot
Europe